文献速递心脏核医学

68Ga-FAPI-04 PET/CT无创追踪压力负荷性心衰小鼠心肌纤维化

Noninvasive tracking of myocardial fibrosis in pressure-overload heart failure with [68Ga]Ga-FAPI-04 PET/CT.
PubMed 文献 · EJNMMI Res · 2026-05-27

研究在横向主动脉缩窄(TAC)C57BL/6J小鼠中评估68Ga-FAPI-04 PET/CT追踪心肌纤维化活性的价值。TAC小鼠术后2周心肌摄取即显著高于假手术组,并随4、8周逐渐增强;心功能在2周时保留,4周出现收缩与舒张功能障碍,8周进一步恶化。阻断实验证实摄取具有靶向特异性,提示FAPI摄取增高早于心功能障碍表现。

要点

  • TAC小鼠心肌68Ga-FAPI-04摄取在术后2周即显著升高,并随4、8周逐渐增强。
  • 心功能2周时保留,4周出现LVEF下降和E/A比值升高,8周进一步恶化。
  • 阻断实验显著抑制心肌摄取,证实FAPI靶向特异性。

核心结论

  • 68Ga-FAPI-04 PET/CT可特异性、无创地追踪心肌纤维化进展,且FAPI摄取增高早于心脏功能障碍出现。

研究设计与样本

  • 在C57BL/6J小鼠中实施横向主动脉缩窄(TAC)建立压力负荷性心衰模型,并于术后2、4、8周行PET/CT与超声心动图检查。

主要发现

  • 与假手术组相比,TAC小鼠术后2周心肌68Ga-FAPI-04摄取显著升高,4周和8周进行性增强。
  • TAC小鼠2周时心功能保留,4周出现LVEF下降与E/A比值升高的收缩和舒张功能障碍,8周进一步恶化。
  • 组织学(WGA、天狼星红、Masson)与放射自显影显示进行性心肌细胞肥大,伴胶原沉积与FAP特异性信号时间依赖性增加。
  • 阻断实验显著抑制心肌摄取,确认靶向特异性。

临床怎么用

  • 68Ga-FAPI-04 PET/CT有望用于心衰早期检测与纵向监测,可在心功能障碍出现前提示心肌纤维化活动。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Myocardial fibrosis is a major driver of heart failure progression, yet noninvasive tools to track its activity are limited. We evaluated fibroblast activation protein (FAP)-targeted [68Ga]Ga-FAPI-04 (FAPI = FAP inhibitor) positron emission tomography/computed tomography (PET/CT) in C57BL/6J mice subjected to transverse aortic constriction (TAC). RESULTS: PET/CT and echocardiography were performed at 2, 4, and 8 weeks post-surgery. Compared to the sham group, TAC mice exhibited significantly elevated myocardial [68Ga]Ga-FAPI-04 uptake at week 2, with progressive intensification at weeks 4 and 8. Although cardiac function remained preserved at week 2, pronounced systolic and diastolic dysfunction (decreased left ventricular ejection fraction [LVEF] and elevated E/A ratio) developed by week 4, deteriorating further by week 8. Correspondingly, histological (wheat germ agglutinin [WGA], Sirius Red, Masson's) and autoradiographic analyses revealed progressive cardiomyocyte hypertrophy, accompanied by time-dependent increases in collagen deposition and FAP-specific signals. Importantly, a blocking experiment significantly suppressed myocardial uptake, confirming targeting specificity. CONCLUSIONS: [68Ga]Ga-FAPI-04 PET/CT provides a specific, noninvasive method to track the progression of myocardial fibrosis. Crucially, increased FAPI uptake precedes the manifestation of cardiac dysfunction, highlighting its significant potential as a promising imaging tool for the early detection and longitudinal monitoring of heart failure.

来源:EJNMMI Res,查看原文。版权归原作者所有。

引用

  1. Liu S, Wen H, Han B, et al. Noninvasive tracking of myocardial fibrosis in pressure-overload heart failure with [68Ga]Ga-FAPI-04 PET/CT. EJNMMI Res. 2026. PMID: 42201501. doi:10.1186/s13550-026-01461-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。